-
Most Recent

Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.

The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Recent Biotech Stocks Articles
Vertex’s Promise Needs to Become Profits
The company hasn't shown it can stop losing money
Biotech Stock Zalicus Soaring in 2011
ZLCS stock is up over 40% in 2011 even after some profit-taking, and Michael Murphy expects the biotech to build on its run in the months ahead.
Shire Shares Shine as a Takeover Target
This growing company may be unable to avoid a sweet offer.
Ariad Could be Summer’s Breakout Biotech
The results from trials of a revolutionary cancer treatment could launch biotech stock Ariad Pharmaceuticals Inc. (NASDAQ: ARIA).
4 Top Biotech Stocks Waging the War on Cancer
A number of companies are creating better treatments for patients and opportunities for investors.
Compugen — Your Typical Biotech Stock Gamble
The company is low on cash but high on Big Pharma partners.
Cancer Drug Should Take Dendreon to $360
Dendreon Corp. (NASDAQ: DNDN) revolutionary cancer vaccine Provenge should make this biotech stock a huge winner.
Illumina Leads Race for Gene-Sequencing Payday
This market could explode to $100 billion a year.
Big Pharma Sees Big Things in India
Outsiders already have one-quarter of this booming market.